Skip to main content
Caplight Logo









Dxcover

Dxcover

Private
GlasgowHealthcare & Life Scienceshttps://dxcover.com/

Last Round

VC Round

Feb 3, 2025

Total Funding Raised

$21.95M

Company Overview

Dxcover is a clinical-stage diagnostics company that provides a liquid biopsy platform using infrared spectroscopy and artificial intelligence for the early detection of multiple cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

liquid biopsymulti-cancer early detectioncancer diagnosticsinfrared spectroscopyATR-FTIRmedical AIcancer screeningprecision medicinediagnostic platformbrain tumor diagnosticsblood-based testingAI diagnosticsbiotechclinical diagnosticsMCED

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dxcover Comparables

Compare Dxcover with similar companies based on industry and business-model similarity.

Dxcover comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CanSense
84%
Oncodea
83%
Elypta
80%

Dxcover Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 3, 2025
VC RoundFeb 5, 2024
GrantFeb 1, 2023
Series AFeb 1, 2023
SeedMar 4, 2021
Seed
Sep 7, 2020

Key People

Founding team and executive leadership

Matthew J. Baker

President Chief Executive Officer, Chief Executive Officer

Executive Team

Dxcover Investors

Notable investors and investment history

Dxcover investors
InvestorRounds
European Innovation Council FundGrant
University of StrathclydeVC Round, Seed, Series A
Mercia Asset ManagementSeries A
Eos AdvisorySeed, VC Round, Series A
European Innovation Council FundGrant
Alba EquitySeed
Social Investment Scotland (SIS) VenturesVC Round, Seed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 26, 2025

    Added ESMO, a medical society, as a customer.

  • Nov 26, 2025

    Added Life Sciences Awards, a media/events startup, as a customer.

Dxcover Filings

Explore SEC and related filing metadata, where available.

Dxcover filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dxcover's valuation, stock price, and market status.

Is Dxcover a public or private company?

Dxcover is a private company.

What is the current stock price of Dxcover?

Dxcover is a private company with no public stock price. No recent secondary market data is available.

How much is Dxcover worth (valuation)?

Valuation information for Dxcover is not publicly available.

Can I buy Dxcover stock?

Dxcover shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dxcover's last funding round?

Dxcover's most recent funding round was VC Round on February 5, 2024.

Who are the main investors in Dxcover?

Key investors in Dxcover include Eos Advisory, Mercia Ventures.

Will Dxcover IPO soon?

No public IPO plans have been announced for Dxcover.

How can I track Dxcover secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dxcover's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGlasgow
Employee Range25
Year Founded2016
Last FundingFeb 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?